Effects of adenovirus vectors mediated human lactoferrin cDNA on mice bearing EMT6 breast carcinoma.

Jianjie Wang,Qingwang Li,Kun Li,Yetao Ou,Zengsheng Han,Dawei Gao,Jian Li
DOI: https://doi.org/10.1691/ph.2011.1534
2011-01-01
Pharmazie
Abstract:Human lactoferrin (hLTF) is an 80KD iron-binding protein. It has been reported that hLTF exists anti-tumor effects. In this study Adenovirus Vectors Mediated Human Lactoferrin cDNA (ad-rhLTF) was constructed and an antitumor effects of ad-rhLTF were investigated in mice bearing EMT6 breast carcinoma. The results demonstrated that ad-rhLTF (5 x 10(8) and 25 x 10(8) pfu/ml local injection) had high expression in tumor tissues and effectively reduced the weight of EMT6 breast tumors. Compared with the control group, cell cycle assay by flow cytometry showed that ad-rhLTF increased the percentage of tumor cells in the Sub-G(1) phase and G(0)/G(1) phase and the apoptotic number reached to 23.2% in ad-rhLTF group (25 x 10(8) pfu/ml). Ad-rhLTF treatment also resulted in a decrease of Bcl-2 and an increase in Bax and caspase 3 expressions, which was demonstrated by immunohistochemical analysis and RT-PCR. These data suggest that the antitumor effects of ad-rhLTF might be associated with arresting tumor cells in the G(0)/G(1) phase, inducing cell apoptosis and regulation of the expression of Bcl-2, Bax and activation of caspase 3.
What problem does this paper attempt to address?